Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | P2RX4 | Q99571 | 8/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SCN4A | P35499 | 1/20 | 0.39 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.39 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.39 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.39 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2607158 | 0.84 | MAPT (0.49) | MAPTKMT2AMEN1NPSR1LMNA | |
| SCHEMBL10086947 | 0.75 | MAPT (0.54) | MAPTKMT2AMEN1NPSR1LMNA | |
| SCHEMBL18136099 | 0.74 | P2RX4 (0.44) | MAPTKMT2AMEN1NPSR1LMNA | |
| SCHEMBL21507788 | 0.74 | MAPT (0.40) | MAPTKMT2AMEN1NPSR1LMNA | |
| SCHEMBL10064684 | 0.74 | P2RX4 (0.43) | MAPTKMT2AMEN1NPSR1LMNA | |
| SCHEMBL23240871 | 0.72 | MGLL (0.48) | MAPTKMT2AMEN1LMNAP2RX4 | |
| SCHEMBL18926940 | 0.72 | P2RX4 (0.44) | MAPTKMT2AMEN1NPSR1P2RX4 | |
| SCHEMBL10449116 | 0.71 | CES1 (0.48) | MAPTKMT2AMEN1MAPK1MTNR1A | |
| SCHEMBL6095161 | 0.71 | MAOA (0.44) | MAPTKMT2AMEN1NPSR1LMNA | |
| SCHEMBL14804047 | 0.70 | NR1H3 (0.42) | LMNAGAAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022004889-A1 | INFRARED BLOCKING FILTER, FILTER FOR SOLID-STATE IMAGING ELEMENT, SOLID-STATE IMAGING ELEMENT, AND METHOD FOR PRODUCING FILTER FOR SOLID-STATE IMAGING ELEMENT | 凸版印刷株式会社 | 2022-01-06 | — | — | WO | disclosed |
| WO-2021145456-A1 | INFRARED BLOCKING FILTER, FILTER FOR SOLID-STATE IMAGING ELEMENT, SOLID-STATE IMAGING ELEMENT, AND METHOD FOR PRODUCING FILTER FOR SOLID-STATE IMAGING ELEMENT | 凸版印刷株式会社 | 2021-07-22 | — | — | WO | disclosed |
| US-9881745-B2 | Dye sensitized solar cell | ADEKA CORPORATION (JP) | 2018-01-30 | — | — | US | disclosed |
| US-20170267717-A1 | Novel method for the production of 18F-labeled active esters and their application exemplified by the preparation of a PSMA-specific PET-tracer | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2017-09-21 | — | — | US | disclosed |
| US-20170216332-A1 | SMALL MOLECULE ANTI-SCARRING AGENTS | UNIVERSITY OF ROCHESTER (US) | 2017-08-03 | — | — | US | disclosed |
| US-9604490-B2 | Color laser marking | AGFA-GEVAERT (BE) | 2017-03-28 | — | — | US | disclosed |
| US-20160148758-A1 | DYE SENSITIZED SOLAR CELL | ADEKA CORPORATION (JP) | 2016-05-26 | — | — | US | disclosed |
| US-9239408-B2 | Colored photosensitive composition | ADEKA CORPORATION (JP) | 2016-01-19 | — | — | US | disclosed |
| US-9110350-B2 | Color conversion filter | ADEKA CORPORATION (JP) | 2015-08-18 | — | — | US | disclosed |
| US-20130306920-A1 | COLORED PHOTOSENSITIVE COMPOSITION | ADEKA CORPORATION (JP) | 2013-11-21 | — | — | US | disclosed |
| US-20130237539-A1 | Compounds and Compositions for Treating Cancer | THE GENERAL HOSPITAL CORPORATION (US) | 2013-09-12 | — | — | US | disclosed |
| US-20130203757-A1 | Compounds And Compositions For Treating Cancer | THE GENERAL HOSPITAL CORPORATION (US) | 2013-08-08 | — | — | US | disclosed |
| US-20130147345-A1 | COLOR CONVERSION FILTER | ADEKA CORPORATION (JP) | 2013-06-13 | — | — | US | disclosed |
| EP-2010494-B1 | SPECIFIC MONOCATIONIC MONOCHROMOPHORIC COMPOUNDS OF HYDRAZONE TYPE COMPRISING A 2-, 4-PYRIDINIUM OR 2-, 4-QUINOLINIUM UNIT, SYNTHESIS THEREOF, DYE COMPOSITIONS CONTAINING THEM, AND METHOD FOR DYEING KERATIN FIBRES | OREAL (FR) | 2012-02-01 | — | — | EP | disclosed |
| US-8012220-B2 | Specific monocationic monochromophoric compounds of hydrazone type comprising a 2-, 4-pyridinium or 2-, 4-quinolinium unit, synthesis thereof, dye compositions containing them, and method for dyeing keratin fibres | L'OREAL S.A. (FR) | 2011-09-06 | — | — | US | disclosed |
| US-8012220-B2 | Specific monocationic monochromophoric compounds of hydrazone type comprising a 2-, 4-pyridinium or 2-, 4-quinolinium unit, synthesis thereof, dye compositions containing them, and method for dyeing keratin fibres | L'OREAL S.A. (FR) | 2011-09-06 | — | — | US | disclosed |
| US-20090300856-A1 | SPECIFIC MONOCATIONIC MONOCHROMOPHORIC COMPOUNDS OF HYDRAZONE TYPE COMPRISING A 2-, 4-PYRIDINIUM OR 2-, 4-QUINOLINIUM UNIT, SYNTHESIS THEREOF, DYE COMPOSITIONS CONTAINING THEM, AND METHOD FOR DYEING KERATIN FIBRES | L'OREAL S.A. (FR) | 2009-12-10 | — | — | US | disclosed |
| US-20090300856-A1 | SPECIFIC MONOCATIONIC MONOCHROMOPHORIC COMPOUNDS OF HYDRAZONE TYPE COMPRISING A 2-, 4-PYRIDINIUM OR 2-, 4-QUINOLINIUM UNIT, SYNTHESIS THEREOF, DYE COMPOSITIONS CONTAINING THEM, AND METHOD FOR DYEING KERATIN FIBRES | L'OREAL S.A. (FR) | 2009-12-10 | — | — | US | disclosed |
| WO-2007125238-A1 | SPECIFIC MONOCATIONIC MONOCHROMOPHORIC COMPOUNDS OF HYDRAZONE TYPE COMPRISING A 2-, 4-PYRIDINIUM OR 2-, 4-QUINOLINIUM UNIT, SYNTHESIS THEREOF, DYE COMPOSITIONS CONTAINING THEM, AND METHOD FOR DYEING KERATIN FIBRES | L'ORÉAL (FR) | 2007-11-08 | — | — | WO | disclosed |
| EP-0892411-B1 | Methine dye sensitized semiconductor particle | FUJIFILM CORP (JP) | 2007-09-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090300856-A1 | SPECIFIC MONOCATIONIC MONOCHROMOPHORIC COMPOUNDS OF HYDRAZONE TYPE COMPRISING A 2-, 4-PYRIDINIUM OR 2-, 4-QUINOLINIUM UNIT, SYNTHESIS THEREOF, DYE COMPOSITIONS CONTAINING THEM, AND METHOD FOR DYEING KERATIN FIBRES | KRT18, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, H1-5 | MAPT 2118/4885KMT2A 732/4885MEN1 2261/4885 |
| US-20170216332-A1 | SMALL MOLECULE ANTI-SCARRING AGENTS | COLGALT1, MMP1, FIBP | MAPT 4802/4885KMT2A 3498/4885MEN1 4453/4885 |
| US-20170267717-A1 | Novel method for the production of 18F-labeled active esters and their application exemplified by the preparation of a PSMA-specific PET-tracer | FGB, F13B, FAP | MAPT 1644/4885KMT2A 2206/4885MEN1 288/4885 |
| US-20130203757-A1 | Compounds And Compositions For Treating Cancer | NQO1, HCCS, TXNRD2 | MAPT 2852/4885KMT2A 2855/4885MEN1 2046/4885 |
| US-20130237539-A1 | Compounds and Compositions for Treating Cancer | NQO1, HCCS, TXNRD2 | MAPT 2852/4885KMT2A 2855/4885MEN1 2046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.